Autres langues Elementis plc

Actions

ELM

GB0002418548

Chimie de spécialité

Temps réel estimé 12:26:40 24/09/2026 Varia. 5j. Varia. 1 janv.
178,00 GBX -0,22% Graphique intraday de Elementis plc +3,02% +6,99%

Autres langues

22/09 Elementis : Meet Elementis at in-cosmetics Latin America 2026
16/09 Elementis PLC Announces Appointment of Christine Soden to Senior Independent Director, Effective September 16, 2026
09/09 Victrex raises annual guidance as "strong momentum" continues
09/09 Victrex ups outlook; Aberdeen names new chair
31/07 Morgan Stanley raises Mondi; RBC cuts Greggs
30/07 Elementis plc Declares Interim Dividend for Six Months Ended June 30, 2026, Payable on 25 September 2026
30/07 EARNINGS AND TRADING: Elementis dividend up 15%; Kier EUR500m contract
30/07 Tranche Update on Elementis plc's Equity Buyback Plan announced on June 3, 2026.
30/07 Elementis plc Reports Earnings Results for the Half Year Ended June 30, 2026
30/07 Elementis Swings to H1 Profit; Revenue Jumps
30/07 Earnings Flash (ELM.L) Elementis plc Posts H1 EPS $0.08
30/07 Earnings Flash (ELM.L) Elementis plc Reports H1 Revenue $318.2M
30/07 Tranche Update on Elementis plc's Equity Buyback Plan announced on May 30, 2025.
10/07 Citi and Jefferies say buy Astra after tumble
09/07 FTSE 100 misses out on rebound as Astra drops
09/07 WINNERS & LOSERS: Astra down on failed test; Computacenter ups outlook
03/06 Elementis : Completion of sale of pharmaceutical manufacturing business
03/06 Elementis starts up to GBP25 million buyback programme
03/06 Elementis : Commencement of share buyback programme
03/06 Elementis Kicks Off GBP25 Million Share Repurchase Program
03/06 Elementis plc commences an Equity Buyback for 56,931,567 shares, representing 10% of its issued share capital, under the authorization approved on April 29, 2026.
02/06 Miners lift FTSE 100 while oil price heads lower
02/06 FTSE up as midcaps outpace blue chips; oil lower
02/06 WINNERS & LOSERS: BAT hit by weaker outlook; Entain gains on bid talk
02/06 Elementis to kick start EUR30 million buyback as completes pharma sale
Aucun résultat pour cette recherche